BiotechTube

Bacillus Clausii Multi ATB Resist + Placebo

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Diarrhea, Infantile

Conditions

Diarrhea, Infantile

Trial Timeline

Jul 1, 2006 → —

NCT ID
NCT00447161

About Bacillus Clausii Multi ATB Resist + Placebo

Bacillus Clausii Multi ATB Resist + Placebo is a approved stage product being developed by Sanofi for Diarrhea, Infantile. The current trial status is completed. This product is registered under clinical trial identifier NCT00447161. Target conditions include Diarrhea, Infantile.

What happened to similar drugs?

8 of 20 similar drugs in Diarrhea, Infantile were approved

Approved (8) Terminated (4) Active (10)
🔄YM060 + PlaceboAstellas PharmaPhase 3
🔄Fidaxomicin oral suspension + Fidaxomicin tablets + Vancomycin oral liquid + Vancomycin capsulesAstellas PharmaPhase 3
🔄YM060Astellas PharmaPhase 3
✅loperamide-simethicone + matching placeboJohnson & JohnsonApproved
✅Loperamide/simeticone 2 mg/125 mg caplets + Loperamide/simeticone 2 mg/125 mg chewable tablets + Probiotic Saccharomyces boulardii 250 mg capsulesJohnson & JohnsonApproved
🔄fidaxomicin + PlaceboMerckPhase 3
✅RV5 (Pentavalent Rotavirus Vaccine)MerckApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00447161ApprovedCompleted

Competing Products

20 competing products in Diarrhea, Infantile

See all competitors
ProductCompanyStageHype Score
Metronidazole + Metronidazole-DRF1 + Metronidazole-DRF2Dr. Reddy's LaboratoriesPhase 2
32
YM060 + PlaceboAstellas PharmaPhase 3
40
Fidaxomicin oral suspension + Fidaxomicin tablets + Vancomycin oral liquid + Vancomycin capsulesAstellas PharmaPhase 3
40
YM060Astellas PharmaPhase 3
40
RamosetronAstellas PharmaPre-clinical
26
Racecadotril Film-Coated Tablet (FCT) + Racecadotril CapsuleJohnson & JohnsonPhase 1
29
loperamide-simethicone + matching placeboJohnson & JohnsonApproved
43
Racecadotril + Racecadotril + Racecadotril + RacecadotrilJohnson & JohnsonPhase 1
29
Loperamide/simeticone 2 mg/125 mg caplets + Loperamide/simeticone 2 mg/125 mg chewable tablets + Probiotic Saccharomyces boulardii 250 mg capsulesJohnson & JohnsonApproved
43
fidaxomicin + PlaceboMerckPhase 3
40
Surotomycin + PlaceboMerckPhase 1
29
Surotomycin + PlaceboMerckPhase 1
29
OPT-80MerckPhase 2
35
fidaxomicinMerckPhase 2
35
RV5 (Pentavalent Rotavirus Vaccine)MerckApproved
43
LJN452 + Placebo to LJN452NovartisPhase 2
35
Octreotide Long Acting ReleaseNovartisPhase 3
40
DNK333 + PlaceboNovartisPhase 2
35
Probiotic SupplementRochePre-clinical
26
Etrasimod + Placebo + CorticosteroidsPfizerPhase 2
27